Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys: 936 trades; $2B in total
Open-market sales: 1,049 trades; $2.3B in total
Insiders filing: 470 insiders; Last 7 days
Companies with several buyers: 27; Last 7 days

Nasus Pharma NSRX

		Trade type
Dan Benjamin TelemanCEO	Nasus PharmaNSRX	Open-market buy	06/17	06/22	6,550 sh	$3.10	$20,305	+4.2%
Dan Benjamin TelemanCEO	Nasus PharmaNSRX	Open-market buy	04/22	04/22	2,900 sh	$3.76	$10,904	+1.9%
Dan Benjamin TelemanCEO	Nasus PharmaNSRX	Open-market buy	03/31	04/01	15,000 sh	$2.04	$30,600	+240.2%